Bumetanide Nasal Spray (Bumetanide)-Enbumyst Dosage and Usage
Bumetanide Nasal Spray (Bumetanide) -Enbumyst is a drug used to treat edema associated with congestive heart failure, liver and kidney disease, including adult nephrotic syndrome. In clinical practice, Enbumyst is widely used for its effective diuretic effect. Its main mechanism of action is to inhibit the reabsorption of sodium ions in the renal tubules, thereby promoting the excretion of urine, reducing the accumulation of excess fluid in the body, and relieving the patient's edema symptoms.
Regarding the usage and dosage of Enbumyst, the first thing to emphasize is that the recommended dose is 0.5 mg of Bumetanide per unit dose of nasal spray. The usual total daily dose for patients is generally between 0.5 mg and 2 mg, and a once-daily spray is usually recommended. The exact number of nasal spray devices required for a single dose depends on the specific dosage prescribed by your doctor. Based on the patient's response to treatment, doctors can personalize the dose, but it should be noted that the highest dose should not exceed 2 mg/day.
It should be noted that Enbumyst is not suitable for long-term use. Its main purpose is to provide patients with a short-term diuretic effect. In general, oral diuretics should be replaced as soon as possible to reduce reliance on nasal use. In addition, the ratio of Enbumyst to oral diuretics is approximately 1:40 and to intravenous agents is approximately 1:20, information that is critical for clinicians when making dose conversions.
In terms of medication management,Enbumyst is for nasal use only, and each spray device is single-use and can provide 0.5 mg of Bumetanide after activation. To ensure the safety and effectiveness of the medication, patients should avoid setting or attempting to reuse this medication for more than one administration. In addition, Enbumyst should be sprayed directly into the nasal cavity when used, rather than against the nasal wall. If the prescribed dose requires multiple sprays, it is recommended to alternate between the left and right nostrils to avoid local irritation.
Reference materials:https://www.drugs.com/enbumyst.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)